Therefore, we hypothesized that the soluble klotho could inhibit systemic and local synovial inflammation in RA patients by suppressing the production of inflammatory factors such as tumor necrosis factor and IL-6, and participate in the regulation of local synovial cell proliferation and pannus to improve disease activity and prognosis. This evidence concerns the gene KL and rheumatoid arthritis.